Dr. Thomas Hauser graduated from the University of Chicago Pritzker School of Medicine with honors after studying Chemistry and Physics at Harvard University. He completed internship, residency, and cardiology fellowship at Beth Israel Deaconess Medical Center, with additional training in cardiovascular magnetic resonance. He subsequently obtained training in nuclear cardiology at Brigham and Women’s Hospital and additional experience in cardiac computed tomography at Massachusetts General Hospital. He also received a Master in Medical Science degree from Harvard Medical School and a Master of Public Health degree from the Harvard T. H. Chan School of Public Health. After his training, he joined the faculty of the Cardiovascular Division at Beth Israel Deaconess Medical Center, where he served as Director of Nuclear Cardiology and Assistant Professor of Medicine at Harvard Medicine School. His research interests have been broad, with a general focus on the use of cardiovascular imaging to elucidate cardiovascular pathophysiology including atrial fibrillation and coronary atherosclerosis. He has authored more than 80 original articles, reviews, and book chapters. His work has been funded by both the National Institutes of Health and industry partners. He also frequently served on data safety monitoring and clinical endpoint committees. While at the Beth Israel Deaconess Medical Center, he was a long time member and vice-chair of the Institutional Review Board. He completed a Fellowship in Bioethics at Harvard Medical School and subsequently joined the clinical ethics team, performing ethics consults addressing complicated medical and ethical scenarios. In 2022, Dr. Hauser joined Novartis Institute of Biomedical Research as Director, Translational Medicine for Cardiometabolic Disease, engaged in drug discovery and development with a focus on proof of concept studies. He continues in patient care at Beth Israel Deaconess Medical Center.